Contact Jacoby & Meyers
Dangerous Drug Lawyers
Call us Today 800-977-5614

Coagulation Factor VIIa Recombinant is used to help treat hemophilia, a blood condition in which the blood doesn’t clot properly, causing excessive bleeding from minor injuries. This medication is infused in combination with blood transfusions so that the body doesn’t view transfused clotting factors as foreign invaders and try to attack them.
Warnings/Side Effects
Patients who take this drug are at increased risk of blood clots forming inside the arteries. This can impede the proper flow of blood through the body and lead to serious complications. If blood clots block blood flow significantly enough, cells won’t get enough oxygen and will die. This can lead to strokes.
Lawyer Advertising. This website is designed for general information only, and in no way is intended to constitute legal advice nor the formation of a lawyer/client relationship without a signed, written agreement. Testimonials or endorsements do not constitute a guarantee, warranty, or prediction regarding the outcome of your legal matter. You pay no fees or costs unless we recover for you. This website contains dramatizations. Prior results are not a guarantee of a future outcome. Jacoby & Meyers does not accept all cases and works cooperatively with co-counsel and/or other law firms with whom it has joint agreements who might potentially handle your cases. We look forward to helping you with your claim.
© 2012-2025 Jacoby & Meyers. All rights reserved.